Abstract:OBJECTIVE:This functional magnetic resonance imaging (fMRI) study investigated the effects of pharmacotherapy on brain function underlying affect dysregulation and cognitive function in pediatric bipolar disorder (PBD).METHOD:Healthy controls (HC) (n=14; mean age =14.1 ± 2.4 years) and unmedicated PBD patients with manic or hypomanic episodes (n=17; mean age =14.3 ± 1.1 years) were matched on intelligence quotient (IQ) and demographic factors. The fMRI studies were performed at baseline and after 14 weeks, during which PBD patients were treated initially with second-generation antipsychotics (SGAs) followed by lamotrigine monotherapy. The pediatric affective color-matching task was used where subjects matched the color of a positive, negative, or neutral word with one of the two colored circles below in each of the trials. There were five blocks of each emotional word type, with 10 trials per block.RESULTS:Behavioral data showed that the PBD group was modestly slower and less accurate than the HC, regardless of condition or treatment status. The blood oxygen level-dependent (BOLD) signal activity was reduced with treatment in the PBD group relative to the HC group during the negative versus neutral condition in bilateral dorsolateral prefrontal cortex (DLPFC), right posterior cingulate gyrus, parahippocampal gyrus, and inferior parietal lobule, but increased in left ventromedial prefrontal cortex (VMPFC). Similarly, during the positive versus neutral condition, the PBD group, relative to HC, showed reduced activity in right DLPFC, precuneus, and inferior parietal lobule and increased activity in the right VMPFC. However, within the PBD group, there was treatment related decrease in VMPFC and DLPFC. Improvement on Young Mania Rating Scale (YMRS) score significantly correlated with the decreased activity in VMPFC within the patient group.CONCLUSIONS:Pharmacotherapy in PBD patients led to differential effort with persistently increased activity in the affective regions and decreased activity in the cognitive regions relative to HC, demonstrating altered mechanisms of affective and cognitive systems of brain function, regardless of symptom response.

P11 Expression and PET in Bipolar Disorders.

Abnormal Perfusion Fluctuation and Perfusion Connectivity in Bipolar Disorder Measured by Dynamic Arterial Spin Labeling.

Circulating T-cell Subsets Discrepancy Between Bipolar Disorder and Major Depressive Disorder During Mood Episodes: A Naturalistic, Retrospective Study of 1015 Cases

Different Oxytocin and Corticotropin-Releasing Hormone System Changes in Bipolar Disorder and Major Depressive Disorder Patients

Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.

Circulating T Lymphocyte Subsets, Cytokines, and Immune Checkpoint Inhibitors in Patients with Bipolar II or Major Depression: a Preliminary Study

P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide.

P300 components of auditory event-related potentials in bipolar and unipolar depressive disorder

Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy Controls

Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder

Alterations in CRY2 and PER3 gene expression associated with thalamic-limbic community structural abnormalities in patients with bipolar depression or unipolar depression

T21. ALTERATIONS OF CRY2 AND PER3 GENE EXPRESSION ARE ASSOCIATED WITH GRAY MATTER ABNORMALITIES OF THALAMIC-LIMBIC NETWORK IN UNIPOLAR DEPRESSION AND BIPOLAR DEPRESSION

Brain-derived neurotrophic factor gene mRNA and protein expression in patients with bipolar disorder

Frontoparietal network homogeneity as a biomarker for mania and remitted bipolar disorder and a predictor of early treatment response in bipolar mania patient

Plasma and Platelet Brain-Derived Neurotrophic Factor (BDNF) Levels in Bipolar Disorder Patients with Post-Traumatic Stress Disorder (PTSD) or in a Major Depressive Episode Compared to Healthy Controls

A Pharmacological Functional Magnetic Resonance Imaging Study Probing the Interface of Cognitive and Emotional Brain Systems in Pediatric Bipolar Disorder

Altered Amplitude of Low-Frequency Fluctuations in Cognitive Impairment of Pediatric Bipolar Disorder: A Resting-State Fmri Study

Characteristics of Prefrontal Activity During Emotional and Cognitive Processing in Patients with Bipolar Disorder: A Multi-Channel Functional Near-Infrared Spectroscopy Study.

Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

Cerebral glucose metabolism in bipolar disorder: A voxel-based meta-analysis of positron emission tomography studies

Distinct Proteomic Profiles in Prefrontal Subareas of Major Depressive Disorder and Bipolar Disorder Patients